We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Zora Biosciences Commercializes VTT's Biotechnology Expertise

Zora will provide laboratory services to pharmaceutical industry in the area of metabolomics and associated bioinformatics.
News

Cellexus Appoints IUL as its Exclusive Distributor in Austria, Benelux, Germany, the Netherlands and Switzerland

Cellexus Biosystems signs a distribution agreement with IUL Instruments to distribute its range of cell-based reagents and instruments to the biotechnology and biopharmaceutical industries.
News

Wyeth Licenses Drug Targets from Osteoporosis Collaboration with Galapagos

Wyeth licenses three bone anabolic drug targets resulting in a €1.05M milestone payment to Galapagos from their 2003 research agreement in osteoporosis.
News

NiKem Research Srl Enters into Research Service Agreement with InterMune

NiKem will use its medicinal chemistry and early ADMET/PK platform and expertise to design drug-like compounds aimed towards pulmonology targets for InterMune.
News

deCODE biostructures Announces Collaborative Research Agreement with Institut de Recherche Servier

The research collaboration provides Servier with access to deCODE’s expertise in de novo protein crystal structure determination.
News

deCODE biostructures Initiates Research Collaboration with Genus Onocology

Under the agreement, deCODE will conduct gene to structure research on protein targets for Genus Oncology.
News

MFIC Announces Opening of Microfluidics Technology Center

The Microfluidics Technology Center will provide customers full access to the Company’s R&D engineers and product suite.
News

Proteros Biostructures Achieve Milestone in Fragment-Based Protein Crystallography Collaboration

In the collaboration Proteros applies its target know-how, industrial process and proprietary Free Mounting System (FMS™) and Picodropper™ technologies to deliver protein-ligand-structures of active fragments.
News

Gene Network Sciences Announces Cancer Treatment Collaboration with Weill Cornell Medical College

Under the agreement, the parties will use GNS's REFS™ software platform to characterize the synergies between two commonly used classes of cancer drugs.
News

Inovio’s Selective Electrochemical Tumor Ablation Therapy Shows Significant Responses in Breast Cancer Study

Inovio’s Phase I/II study of patients with recurrent breast cancer showed safety, tolerability and achieved a 75% complete tumor response rate.
Advertisement